The role of pharmacogenomics in the tuberculosis treatment regime

The role of pharmacogenomics in the tuberculosis treatment regime

Tuberculosis is a health problem worldwide with one-third of the population infected with the Mycobacterium tuberculosis bacilli. The first-line of treatment for tuberculosis includes the drugs Isoniazid (INH) and Rifampicin (RIF) metabolized in the liver. Drug metabolism is directly related to the...

Full description

Bibliographic Details
Main Authors: Heinner Guio, Kelly S. Levano, Cesar Sánchez, David Tarazona
Format: Article
Language:Spanish
Published: Instituto Nacional de Salud 2015-12-01
Series:Revista Peruana de Medicina Experimental y Salud Pública
Subjects:
farmacogenética
mycobacterium tuberculosis
variación genética
Online Access:https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/1774

Similar Items

Similar Items